We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
AngioDynamics
ANGO
$649M
| $2.26M | ﹤0.01% |
105,048
-819
| -0.8% | -$18.6K |
|
1752
Relay Therapeutics
RLAY
$4.33B
| $2.26M | ﹤0.01% |
75,438
+5,437
| +8% | +$132K |
|
1753
AppFolio
APPF
$7.04B
| $2.26M | ﹤0.01% |
19,928
+535
| +3% | +$61.6K |
|
1754
Frontdoor
FTDR
$6.26B
| $2.25M | ﹤0.01% |
75,522
-4,625
| -6% | -$154K |
|
|
GBT
1755
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.25M | ﹤0.01% |
64,979
+1,876
| +3% | +$56.1K |
|
1756
Revolve Group
RVLV
$1.73B
| $2.25M | ﹤0.01% |
41,888
+613
| +1% | +$31.1K |
|
1757
Outset Medical
OM
$90.8M
| $2.23M | ﹤0.01% |
3,276
+133
| +4% | +$80K |
|
|
ETWO
1758
DELISTED
E2open Parent Holdings
ETWO
| $2.23M | ﹤0.01% |
252,780
-8,036
| -3% | -$73K |
|
1759
Unitil
UTL
$980M
| $2.22M | ﹤0.01% |
44,578
+229
| +0.5% | +$11.2K |
|
|
AGR
1760
DELISTED
Avangrid, Inc.
AGR
| $2.22M | ﹤0.01% |
47,510
+2,072
| +5% | +$95K |
|
|
CCRN
1761
DELISTED
Cross Country Healthcare
CCRN
| $2.22M | ﹤0.01% |
102,294
+2,556
| +3% | +$55.5K |
|
1762
Designer Brands
DBI
$333M
| $2.22M | ﹤0.01% |
164,060
+8,276
| +5% | +$109K |
|
1763
Kelly Services Class A
KELYA
$528M
| $2.22M | ﹤0.01% |
102,157
-88
| -0.1% | -$1.71K |
|
|
FSR
1764
DELISTED
Fisker Inc.
FSR
| $2.21M | ﹤0.01% |
170,940
+3,079
| +2% | +$38.6K |
|
1765
Coursera
COUR
$1.54B
| $2.2M | ﹤0.01% |
95,662
-4,582
| -5% | -$93.9K |
|
1766
Mativ Holdings
MATV
$711M
| $2.2M | ﹤0.01% |
80,079
+1,110
| +1% | +$33.4K |
|
|
TELL
1767
DELISTED
Tellurian Inc.
TELL
| $2.2M | ﹤0.01% |
415,309
+54,611
| +15% | +$184K |
|
1768
Agios Pharmaceuticals
AGIO
$1.93B
| $2.2M | ﹤0.01% |
75,456
-6,309
| -8% | -$193K |
|
|
PING
1769
DELISTED
Ping Identity Holding Corp.
PING
| $2.19M | ﹤0.01% |
79,911
+151
| +0.2% | +$3.17K |
|
1770
Zumiez
ZUMZ
$339M
| $2.19M | ﹤0.01% |
57,191
-4,269
| -7% | -$186K |
|
1771
SunCoke Energy
SXC
$797M
| $2.18M | ﹤0.01% |
245,091
+8,937
| +4% | +$70.4K |
|
1772
Super Micro Computer
SMCI
$20.1B
| $2.18M | ﹤0.01% |
572,850
-66,690
| -10% | -$276K |
|
1773
Core Laboratories
CLB
$521M
| $2.18M | ﹤0.01% |
68,839
+5,931
| +9% | +$166K |
|
|
AAMI
1774
Acadian Asset Management
AAMI
$3.19B
| $2.18M | ﹤0.01% |
89,712
-25,244
| -22% | -$600K |
|
1775
Hanmi Financial
HAFC
$946M
| $2.17M | ﹤0.01% |
88,372
-171
| -0.2% | -$4.41K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.